Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Recap: Lexicon Pharmaceuticals Q2 Earnings

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lexicon Pharmaceuticals reported in-line EPS of $-0.16 versus an estimate of $-0.16.

LXRX

Read More

More Than $40 Million Bet On This Penny Stock? Check Out These 3 Penny Stocks Insiders Are Buying

U.S. gold futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

FTK